Harvard Bioscience
HBIO
#8966
Rank
NZ$0.16 B
Marketcap
$3.73
Share price
0.48%
Change (1 day)
-55.52%
Change (1 year)

Harvard Bioscience (HBIO) - Cash on Hand

Cash on Hand as of September 2024 : NZ$8.07 Million

According to Harvard Bioscience's latest financial reports the company has NZ$8.07 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Harvard Bioscience - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$6.77 M-4.62%
2022-12-31NZ$7.1 M-37.99%
2021-12-31NZ$11.45 M-0.66%
2020-12-31NZ$11.52 M-6.86%
2019-12-31NZ$12.37 M1.57%
2018-12-31NZ$12.18 M66.67%
2017-12-31NZ$7.31 M-9.51%
2016-12-31NZ$8.07 M-18.01%
2015-12-31NZ$9.85 M-45.38%
2014-12-31NZ$18.03 M-42.48%
2013-12-31NZ$31.36 M24.75%
2012-12-31NZ$25.13 M9.51%
2011-12-31NZ$22.95 M-10.12%
2010-12-31NZ$25.54 M11.83%
2009-12-31NZ$22.83 M-3.25%
2008-12-31NZ$23.6 M1.07%
2007-12-31NZ$23.35 M75.84%
2006-12-31NZ$13.28 M18.95%
2005-12-31NZ$11.16 M-42.54%
2004-12-31NZ$19.43 M53.63%
2003-12-31NZ$12.64 M-56.77%
2002-12-31NZ$29.25 M-58.65%
2001-12-31NZ$70.76 M-12.44%
2000-12-31NZ$80.82 M1662.83%
1999-12-31NZ$4.58 M152.48%
1998-12-31NZ$1.81 M